Citizen Petition Requesting an Enforcement Policy Permitting Manufacturers of Single-Ingredient Acetaminophen OTC Drugs to Include Labeling Instructions for Children

Share page:

Petition | Aug 15, 2013

CHPA requests that FDA publish a statement of enforcement policy expressly permitting manufacturers of single-ingredient acetaminophen OTC drugs subject to the ongoing internal analgesic, antipyretic, and antirheumatic monograph proceedings to including labeling on products that provide instructions for use in children aged six months to two years.

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement: OTC Pain Relievers and COVID-19 Vaccines